News | May 21, 2015

Elekta Earns CE Mark for Monaco v5.10 Treatment Planning System

Latest version supports planning for multiple patients simultaneously across multiple treatment techniques

Elekta, Monaco, v5.10, CE Mark

May 21, 2015 — Elekta has CE marked the latest version (v5.10) of its popular Monaco treatment planning system, enabling its sale to European clinics. The system supports major treatment techniques including advanced 3-D planning, intensity modulated radiation therapy (IMRT), volumetric arc therapy (VMAT) and stereotactic planning – all in a single system.

Monaco v5.10 provides significant planning and quality assurance (QA) enhancements, as well improved workflow efficiency. Advancements in 3-D planning as well as the addition of magnetic resonance imaging (MRI) and forward planning capabilities further reinforces Monaco as a robust and flexible treatment planning solution. Now, users can simplify their planning with advanced time-saving tools, speed up workflow and ultimately create better plans with fewer contours and therefore less variability.

Furthermore, utilizing the Monte Carlo algorithm, Monaco now enables users to recalculate third-party plans for quality assurance checks.

Key Monaco v5.10 benefits designed to improve planning time enable clinicians to:

  • Optimize plan creation with customizable templates that can be shared across institutions;
  • Plan multiple patients simultaneously;
  • Achieve better dose conformity with state-of-the art optimization tools;
  • Create multiple prescriptions within a single active plan; and
  • Quickly learn and use the system through its modern, intuitive interface.

 

For more information: www.elekta.com

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Overlay Init